The cardiovascular effects of Wegovy have been extensively studied, with the SELECT trial demonstrating a significant reduction in major adverse cardiovascular events in patients with established cardiovascular disease, though this is not a current UK-licensed indication
Villanueva-Penacarrillo ML, Puente J, Redondo A, Clemente F, Valverde I: Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in type 1 and type 2 rat diabetic models
Choose a center with licensed professionals, clear treatment options, patient success stories, and transparent pricing.
Significant weight reduction can alleviate pressure on the bladder and pelvic floor, potentially improving stress incontinence in some patients, as recognised in NICE guidance (NG123)
[DOI] [PubMed] [Google Scholar] 192.Jacobsen MT et al
--- ## Dose Calculator: 2.5mg/mL Concentration | Semaglutide Dose | Volume (mL) | Insulin Syringe Units | |-----------------|-------------|----------------------| | 0.25mg | 0.10mL | 10 units | | 0.5mg | 0.20mL | 20 units | | 1.0mg | 0.40mL | 40 units | | 1.7mg | 0.68mL | 68 units | | 2.4mg | 0.96mL | 96 units | --- ## 5mg Semaglutide Reconstitution (Most Common Vial Size) The 5mg vial is the standard starter size, typically lasting 410 weeks depending on your dose
